Contact

CleanCap® mRNA Capping

CleanCap® Co-transcriptional Capping Streamlines mRNA Manufacturing

mRNA Expressing Cytosine and Adenine Base Editors Efficiently Mediate Base Corrections In Vitro and In Vivo

Cytosine and Adenine Base Editors Expressed from Messenger RNAs Mediate Efficient Base Corrections In Vitro and In Vivo

mRNA

Strategies to Minimize Innate Immune Stimulation to Maximize Messenger RNA Bioavailability (OTS 2018) 

HPLC Purified Wild-type Cap1 EGFP mRNAs Perform as Well as Pseudouridine Modified mRNAs in Cultured Cells(OTS 2016)

Considerations for the Development, Scale-up and Manufacturing of mRNA Therapeutics

Generating Optimal Pseudouridine and 5-Methylcytidine Modified Messenger RNA for iPS Cell Reprogramming

Novel N1-Substituted Pseudouridine 5’-Triphosphates for the Synthesis of Modified mRNA and its Effect on mRNA Translation in THP-1 cells (SCNAC 2017)

Maximizing Translation of mRNA Therapeutics By Sequence Engineering and Chemical Modification( 7th Cambridge Symposium on Nucleic Acids Chemistry & Biology 2017) 

CRISPR/Cas9

Exploring the Epitranscriptome: Properly Capped and Chemically Modified Cas9 mRNAs For Genome Editing as a Case Study (1st Nucleic Acid Modifications 2017)

Items 1 to 10 of 21 total

Page